New treatment option for Prehypertension (Elevated Blood Pressure) or Hypertension
Official title Difference in Acute Responses of Vascular Function to Moderate-intensity and High-intensity Interval Training in Healthy and Prehypertensive Individuals
ClinicalTrials.gov ID: NCT07048509
What this study is testing
- What it's testing
- In this study, the investigators will evaluate acute changes in vascular function measures after moderate-intensity continuous and high-intensity interval exercise in healthy and prehypertensive individuals. Participants will be subjected to three separate visits: control condition (30 min rest), moderate-intensity continuous exercise, and high-intensity interval exercise.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50. Healthy volunteers may be eligible.
You may be able to join if
- Normotensive participants
- 18 - 50 years of age, BMI \< 30, blood pressure (BP) within the optimal range according to the latest ESH guidelines (\< 120 mmHg systolic and/or \<...
- Sedentary or low active according to the Global Physical Activity Questionnaire (GPAQ) (Armstrong \& Bull, 2006; Lim et al., 2012)
- No prescribed medication and absence of chronic diseases for prehypertensive individuals:
- 18 - 50 years of age, BMI \< 30
You likely can't join if
- Blood pressure out of the optimal range (normotensives)
- High level of phyisical activity (moderate or high active according to GPAQ)
- Hypotension
- Chronic diseases
- Prescribed medication
- Lower extremity injury in the last six months
See the full eligibility criteria
- Normotensive participants
- 18 - 50 years of age, BMI \< 30, blood pressure (BP) within the optimal range according to the latest ESH guidelines (\< 120 mmHg systolic and/or \< 80 mmHg diastolic BP)
- Sedentary or low active according to the Global Physical Activity Questionnaire (GPAQ) (Armstrong \& Bull, 2006; Lim et al., 2012)
- No prescribed medication and absence of chronic diseases for prehypertensive individuals:
- 18 - 50 years of age, BMI \< 30
- Diagnosed prehypertension by a clinican from the Hypertension clinic, University clinical centre of Ljubljana using established criteria
- Sedentary or low or moderately active according to the Global Physical Activity Questionnaire (GPAQ)
- No prescribed medication and absence of chronic diseases
- Blood pressure out of the optimal range (normotensives)
- High level of phyisical activity (moderate or high active according to GPAQ)
- Hypotension
- Chronic diseases
- Prescribed medication
- Lower extremity injury in the last six months
- Menopause
- Absence of normal menstrual cycle
- Pregnancy
- Smoking
The study team makes the final eligibility decision.
Where it's taking place
- Ljubljana, Slovenia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ljubljana, Slovenia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.